BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9699179)

  • 1. Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium.
    Palmer SS; Haynes-Johnson D; Diehl T; Nowak RA
    J Soc Gynecol Investig; 1998; 5(4):203-9. PubMed ID: 9699179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression.
    Dou Q; Tarnuzzer RW; Williams RS; Schultz GS; Chegini N
    Mol Hum Reprod; 1997 Nov; 3(11):1005-14. PubMed ID: 9433928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells.
    Halder SK; Osteen KG; Al-Hendy A
    Hum Reprod; 2013 Sep; 28(9):2407-16. PubMed ID: 23814095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases of human leiomyoma in various stages of tumor growth.
    Wolańska M; Sobolewski K; Bańkowski E; Jaworski S
    Gynecol Obstet Invest; 2004; 58(1):14-8. PubMed ID: 15004438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium.
    Bogusiewicz M; Stryjecka-Zimmer M; Postawski K; Jakimiuk AJ; Rechberger T
    Gynecol Endocrinol; 2007 Sep; 23(9):541-6. PubMed ID: 17943549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of tumor necrosis factor-α on matrix metalloproteinase-2 expression in human myometrial and uterine leiomyoma smooth muscle cells.
    Wang Y; Feng G; Wang J; Zhou Y; Liu Y; Shi Y; Zhu Y; Lin W; Xu Y; Li Z
    Hum Reprod; 2015 Jan; 30(1):61-70. PubMed ID: 25398968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of sex hormone-binding globulin mRNA in uterine leiomyoma, myometrium and endometrium of human subjects.
    Misao R; Nakanishi Y; Fujimoto J; Tamaya T
    Gynecol Endocrinol; 1995 Dec; 9(4):317-23. PubMed ID: 8629461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-human primate models; artificial menstrual cycles, endometrial matrix metalloproteinases and s.c. endometrial grafts.
    Brenner RM; Rudolph L; Matrisian L; Slayden OD
    Hum Reprod; 1996 Oct; 11 Suppl 2():150-64. PubMed ID: 8982757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle.
    Stewart EA; Friedman AJ; Peck K; Nowak RA
    J Clin Endocrinol Metab; 1994 Sep; 79(3):900-6. PubMed ID: 8077380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of mRNAs for endothelin-related proteins in human endometrium, myometrium and leiomyoma.
    Pekonen F; Nyman T; Rutanen EM
    Mol Cell Endocrinol; 1994 Jul; 103(1-2):165-70. PubMed ID: 7958393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative messenger ribonucleic acid analysis of immediate early genes and sex steroid receptors in human leiomyoma and healthy myometrium.
    Lessl M; Klotzbuecher M; Schoen S; Reles A; Stöckemann K; Fuhrmann U
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2596-600. PubMed ID: 9253340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium.
    Ulaner GA; Hu JF; Vu TH; Oruganti H; Giudice LC; Hoffman AR
    Int J Cancer; 2000 Feb; 85(3):330-5. PubMed ID: 10652422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas.
    Sourla A; Polychronakos C; Zeng WR; Nepveu A; Kukuvitis A; Naud F; Koutsilieris M
    Cancer Res; 1996 Jul; 56(13):3123-8. PubMed ID: 8674071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
    Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T
    J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
    Wang H; Wu X; Englund K; Masironi B; Eriksson H; Sahlin L
    Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated expression of collagenases MMP-1, -8, and -13 and stromelysins MMP-3, -10, and -11 by human corneal epithelial cells.
    Li DQ; Shang TY; Kim HS; Solomon A; Lokeshwar BL; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2928-36. PubMed ID: 12824233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
    Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
    Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNAse protection assays for the simultaneous and semiquantitative analysis of multiple murine matrix metalloproteinase (MMP) and MMP inhibitor mRNAs.
    Pagenstecher A; Stalder AK; Campbell IL
    J Immunol Methods; 1997 Aug; 206(1-2):1-9. PubMed ID: 9328562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells.
    Xu Q; Ohara N; Liu J; Amano M; Sitruk-Ware R; Yoshida S; Maruo T
    Mol Hum Reprod; 2008 Mar; 14(3):181-91. PubMed ID: 18216291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of erythropoietin in uterine leiomyoma: implications in tumor growth.
    Asano R; Asai-Sato M; Miyagi Y; Mizushima T; Koyama-Sato M; Nagashima Y; Taguri M; Sakakibara H; Hirahara F; Miyagi E
    Am J Obstet Gynecol; 2015 Aug; 213(2):199.e1-8. PubMed ID: 25724399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.